The State Pharmaceuticals Corporation (SPC) of Sri Lanka will today introduce locally-produced Gabapentin 300mg, to boost local production of pharmaceuticals. The production of the medication is implemented under a program called ‘Aluth Ratata, Aluth Beheth’. Gabapentin is an anticonvulsant or antiepileptic drug used with other medications to prevent and control seizures.

Development of pharmaceutical manufacturing is part of the policy proposals included in President Gotabaya Rajapaksa’s manifesto ‘Vistas of Prosperity and Splendour’ and aims to produce 50% of the country’s pharmaceutical requirement locally.

According to a statement issued by the Pharmaceutical Production, Supply and Regulation State Ministry, the State health sector spends Rs. 14.17 million annually on this particular drug, while the private sector spends Rs. 1.6 million annually. 

Health authorities raise concerns on reduced compliance with COVID-19 regulations